Bruno Julianne
SEC insider (Form 3/4/5 filer). CIK 0002019645. Director at Damora Therapeutics, Inc. (DMRA) and 1 other issuer. 13 reported Form 4/5 transactions since Sep 2024; latest on Mar 23, 2026. Located in WALTHAM, MA.
Companies Bruno Julianne has filed insider reports for
- Damora Therapeutics, Inc. (DMRA): Director
- CRISPR Therapeutics AG (CRSP): Officer, Chief Operating Officer
Bruno Julianne
CIK: 0002019645
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Mar 23, 2026DMRA
Damora Therapeutics, Inc.
AwardDirectStock Option (right to buy)
37.3K shares- - Feb 9, 2026GLTO
Galecto, Inc.
ExerciseDirect129K shares- - Mar 21, 2025CRSP
CRISPR Therapeutics AG
SaleDirect1.7K shares at avg. $41.23$71K - Mar 20, 2025CRSP
CRISPR Therapeutics AG
ExerciseDirect3.8K shares- - Mar 14, 2025CRSP
CRISPR Therapeutics AG
AwardDirectRestricted Stock Units
27.5K shares- - Mar 14, 2025CRSP
CRISPR Therapeutics AG
AwardDirectStock Option (Right to Buy)
36.7K shares- - Mar 12, 2025CRSP
CRISPR Therapeutics AG
SaleDirect190 shares at avg. $43.32$8K - Mar 11, 2025CRSP
CRISPR Therapeutics AG
ExerciseDirect435 shares- - Mar 11, 2025CRSP
CRISPR Therapeutics AG
SaleDirect1.2K shares at avg. $42.42$51K - Mar 10, 2025CRSP
CRISPR Therapeutics AG
ExerciseDirect2.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 23, 2026 |  DMRA Damora Therapeutics, Inc. | Award Stock Option (right to buy) | 37,313 | - | - | Direct |
| Feb 9, 2026 |  GLTO Galecto, Inc. | Exercise | 129,000 | - | $0 | Direct |
| Mar 21, 2025 |  CRSP CRISPR Therapeutics AG | Sale | 1,714 | $41.23 | $70,668 | Direct |
| Mar 20, 2025 | CRSP CRISPR Therapeutics AG | Exercise | 3,750 | - | - | Direct |
| Mar 14, 2025 | CRSP CRISPR Therapeutics AG | Award Restricted Stock Units | 27,500 | - | - | Direct |
| Mar 14, 2025 | CRSP CRISPR Therapeutics AG | Award Stock Option (Right to Buy) | 36,666 | - | - | Direct |
| Mar 12, 2025 | CRSP CRISPR Therapeutics AG | Sale | 190 | $43.32 | $8,231 | Direct |
| Mar 11, 2025 | CRSP CRISPR Therapeutics AG | Exercise | 435 | - | - | Direct |
| Mar 11, 2025 | CRSP CRISPR Therapeutics AG | Sale | 1,198 | $42.42 | $50,819 | Direct |
| Mar 10, 2025 | CRSP CRISPR Therapeutics AG | Exercise | 2,399 | - | - | Direct |
1-10 of 13 transactions